Rxo (RXO) | Financial Analysis & Statements
Rxo Inc. Mid-cap Industrials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.5B
Gross Profit
191.0M
13.00%
Operating Income
-9.0M
-0.61%
Net Income
-46.0M
-3.13%
EPS (Diluted)
$-0.27
Balance Sheet Metrics
Total Assets
3.3B
Total Liabilities
1.7B
Shareholders Equity
1.5B
Debt to Equity
1.13
Cash Flow Metrics
Operating Cash Flow
-81.0M
Free Cash Flow
-9.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Rxo Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.7B | 4.6B | 3.9B | 4.8B | 4.7B |
| Cost of Goods Sold | 4.9B | 3.9B | 3.3B | 3.9B | 4.0B |
| Gross Profit | 825.0M | 696.0M | 658.0M | 860.0M | 735.0M |
| Gross Margin % | 14.4% | 15.3% | 16.8% | 17.9% | 15.7% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 832.0M | 666.0M | 591.0M | 640.0M | 539.0M |
| Other Operating Expenses | - | - | 235.0M | 226.0M | 192.0M |
| Total Operating Expenses | 832.0M | 666.0M | 826.0M | 866.0M | 731.0M |
| Operating Income | -7.0M | 30.0M | 67.0M | 220.0M | 196.0M |
| Operating Margin % | -0.1% | 0.7% | 1.7% | 4.6% | 4.2% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 35.0M | 30.0M | 32.0M | 4.0M | 0 |
| Other Non-Operating Income | -73.0M | -304.0M | -31.0M | -97.0M | -5.0M |
| Pre-tax Income | -115.0M | -304.0M | 4.0M | 119.0M | 191.0M |
| Income Tax | -15.0M | -14.0M | 0 | 27.0M | 41.0M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 22.7% | 21.5% |
| Net Income | -100.0M | -290.0M | 4.0M | 92.0M | 150.0M |
| Net Margin % | -1.7% | -6.4% | 0.1% | 1.9% | 3.2% |
| Key Metrics | |||||
| EBITDA | 108.0M | -101.0M | 131.0M | 306.0M | 276.0M |
| EPS (Basic) | $-0.59 | $-2.14 | $0.03 | $0.80 | $1.30 |
| EPS (Diluted) | $-0.59 | $-2.14 | $0.03 | $0.80 | $1.30 |
| Basic Shares Outstanding | 168462000 | 133412000 | 116871000 | 115335000 | 115113629 |
| Diluted Shares Outstanding | 168462000 | 133412000 | 116871000 | 115335000 | 115113629 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Rxo Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 17.0M | 35.0M | 5.0M | 98.0M | 29.0M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 1.2B | 1.2B | 743.0M | 900.0M | 1.0B |
| Inventory | - | - | - | - | - |
| Other Current Assets | 74.0M | 77.0M | 48.0M | 31.0M | 44.0M |
| Total Current Assets | 1.3B | 1.3B | 796.0M | 1.0B | 1.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 238.0M | 276.0M | 195.0M | 159.0M | 128.0M |
| Goodwill | 2.7B | 2.7B | 1.3B | 1.3B | 1.4B |
| Intangible Assets | 453.0M | 499.0M | 68.0M | 79.0M | 100.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 24.0M | 42.0M | 12.0M | 15.0M | 16.0M |
| Total Non-Current Assets | 2.0B | 2.1B | 1.0B | 1.0B | 985.0M |
| Total Assets | 3.3B | 3.4B | 1.8B | 2.0B | 2.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 539.0M | 568.0M | 414.0M | 501.0M | 520.0M |
| Short-term Debt | 92.0M | 98.0M | 56.0M | 52.0M | 42.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 10.0M | 26.0M | 13.0M | 14.0M | 6.0M |
| Total Current Liabilities | 1.0B | 1.1B | 682.0M | 823.0M | 816.0M |
| Non-Current Liabilities | |||||
| Long-term Debt | 578.0M | 566.0M | 502.0M | 565.0M | 93.0M |
| Deferred Tax Liabilities | 51.0M | 88.0M | 7.0M | 16.0M | 52.0M |
| Other Non-Current Liabilities | 69.0M | 83.0M | 40.0M | 40.0M | 37.0M |
| Total Non-Current Liabilities | 698.0M | 737.0M | 549.0M | 621.0M | 182.0M |
| Total Liabilities | 1.7B | 1.8B | 1.2B | 1.4B | 998.0M |
| Equity | |||||
| Common Stock | 2.0M | 2.0M | 1.0M | 1.0M | 0 |
| Retained Earnings | -384.0M | -284.0M | 6.0M | 2.0M | 0 |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.5B | 1.6B | 594.0M | 587.0M | 1.1B |
| Key Metrics | |||||
| Total Debt | 670.0M | 664.0M | 558.0M | 617.0M | 135.0M |
| Working Capital | 279.0M | 274.0M | 114.0M | 206.0M | 267.0M |
Balance Sheet Composition
Rxo Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -100.0M | -290.0M | 4.0M | 92.0M | 150.0M |
| Depreciation & Amortization | 116.0M | 87.0M | 67.0M | 86.0M | 81.0M |
| Stock-Based Compensation | 29.0M | 23.0M | 19.0M | 32.0M | 8.0M |
| Working Capital Changes | -2.0M | -166.0M | 58.0M | 92.0M | -117.0M |
| Operating Cash Flow | 33.0M | -142.0M | 149.0M | 288.0M | 128.0M |
| Investing Activities | |||||
| Capital Expenditures | -57.0M | -45.0M | -64.0M | -56.0M | -38.0M |
| Acquisitions | -10.0M | -1.0B | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -71.0M | -1.1B | -66.0M | -56.0M | -38.0M |
| Financing Activities | |||||
| Share Repurchases | 0 | 0 | -2.0M | 0 | 0 |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 566.0M | 238.0M | 76.0M | 451.0M | 0 |
| Debt Repayment | -535.0M | -229.0M | -175.0M | 0 | 0 |
| Financing Cash Flow | 1.0M | 1.1B | -117.0M | -183.0M | -158.0M |
| Free Cash Flow | -8.0M | -57.0M | 25.0M | 253.0M | 116.0M |
| Net Change in Cash | -37.0M | -98.0M | -34.0M | 49.0M | -68.0M |
Cash Flow Trend
Rxo Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
645.33
Forward P/E
49.16
Price to Book
2.04
Price to Sales
0.55
PEG Ratio
5.16
Profitability Ratios
Profit Margin
-1.74%
Operating Margin
-0.61%
Return on Equity
-6.34%
Return on Assets
-0.13%
Financial Health
Current Ratio
1.27
Debt to Equity
43.48
Beta
1.52
Per Share Data
EPS (TTM)
$-0.59
Book Value per Share
$9.39
Revenue per Share
$34.09
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| RXO | 3.2B | 645.33 | 2.04 | -6.34% | -1.74% | 43.48 |
| Old Dominion Freight | 46.4B | 46.03 | 10.78 | 23.93% | 18.63% | 3.28 |
| XPO | 26.3B | 84.73 | 14.06 | 18.26% | 3.87% | 223.97 |
| Schneider National | 5.3B | 51.07 | 1.74 | 3.45% | 1.83% | 16.43 |
| ArcBest | 2.7B | 47.16 | 2.13 | 4.61% | 1.50% | 35.86 |
| Saia | 11.8B | 46.27 | 4.55 | 10.43% | 7.89% | 11.83 |
Financial data is updated regularly. All figures are in the company's reporting currency.






